Accepted Manuscript L-C1qDC-1, a novel C1q domain-containing protein from Lethenteron camtschaticum that is involved in the immune response Guangying Pei, Ge Liu, Xiong Pan, Yue Pang, Qingwei Li PII:
S0145-305X(15)30033-1
DOI:
10.1016/j.dci.2015.08.011
Reference:
DCI 2450
To appear in:
Developmental and Comparative Immunology
Received Date: 12 May 2015 Revised Date:
21 August 2015
Accepted Date: 22 August 2015
Please cite this article as: Pei, G., Liu, G., Pan, X., Pang, Y., Li, Q., L-C1qDC-1, a novel C1q domaincontaining protein from Lethenteron camtschaticum that is involved in the immune response, Developmental and Comparative Immunology (2015), doi: 10.1016/j.dci.2015.08.011. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT 1
L-C1qDC-1, a novel C1q domain-containing protein from
2
Lethenteron camtschaticum that is involved in the immune response Guangying Pei1,2, Ge Liu1,2, Xiong Pan1,2, Yue Pang1,2*, Qingwei Li1,2*
4
1
, College of Life Science, Liaoning Normal University, Dalian 116081, China
5
2
, Lamprey Research Center, Liaoning Normal University, Dalian 116081, China
6
* Corresponding author: Qingwei Li, Yue Pang
7
Telephone and Fax: 0086-411-85827799.
8
E-mail:
[email protected];
[email protected]
9
25 Pages, 6 Figures, 1 Supplementary Figures, 0 Supplementary Tables
SC
M AN U
10
RI PT
3
Abbreviations:
gC1q, globular C1q; L.camtschaticum, Lethenteron camtschaticum; C1qDC, C1q
12
domain-containing; ghC1q, globular head C1q; VLRs, variable lymphocyte receptors;
13
MBL, mannose-binding lectin; MASPs, MBL-associated serine proteases; FRP,
14
fiber-reinforced plastic; BLASTx, Basic Local Alignment Search Tool X; NCBI,
15
National Center for Biotechnology Information; NJ, neighbor-joining; ORF, open
16
reading frame; RACE, rapid amplification of cDNA ends; IPTG, isopropyl
17
β-D-thiogalactopyranoside; BCA, bicinchoninic acid; CFA, complete Freund’s
18
adjuvant;
19
3-aminopropyltriethoxy
20
chemiluminescence; DAPI, 4’,6-diamidino-2-phenylindole; CCD, charge-coupled
21
device; UTR, untranslated region; ELISA, enzyme-linked immunosorbent assay; TNF,
AC C
EP
TE D
11
GAPDH,
glyceraldehyde3-phosphate silane;
DAB,
1
dehydrogenase;
diaminobenzidine;
ECL,
APES, enhanced
ACCEPTED MANUSCRIPT 22
tumor necrosis factor.
23
Abstract: The C1q domain-containing (C1qDC) proteins are a family of proteins
25
characterized by a globular C1q (gC1q) domain at their C-terminus. These proteins
26
are involved in various processes in vertebrates and are assumed to serve as important
27
pattern recognition receptors in innate immunity in invertebrates. Here, a novel
28
C1qDC protein from Lethenteron camtschaticum was identified and characterized
29
(designated as L-C1qDC-1). After a partial cDNA sequence of L-C1qDC-1 was
30
identified in a L.camtschaticum liver cDNA library, the full-length cDNA was
31
obtained using 3’- and 5’-rapid amplification of cDNA ends (RACE). L-C1qDC-1
32
encodes 236 amino acids and contains a signal peptide, a collagen-like sequence with
33
Gly-Xaa-Yaa repeats, and a C-terminal gC1q domain. The L-C1qDC-1 protein was
34
primarily distributed in the gut, liver and supraneural body of L.camtschaticum and
35
was
36
immunofluorescence
37
immunofluorescence results showed that in L. camtschaticum serum, L-C1qDC-1
38
could interact with variable lymphocyte receptor (VLR) B and displayed strong
39
colocalization with cancer cell immune responses. These results indicated that the
40
L-C1qDC-1 gene encodes a novel C1qDC protein that may play an important role in
41
the immune responses of L.camtschaticum, providing clues for understanding the
42
universal functions of C1qDC proteins in other species and suggesting that these
43
proteins could serve as pattern recognition molecules in immunotherapy.
marginally
detectable
EP
also
TE D
M AN U
SC
RI PT
24
leukocytes
Furthermore,
both
via
real-time
PCR
and
immunoprecipitation
and
AC C
assays.
in
2
ACCEPTED MANUSCRIPT 44
Keywords: Lethenteron camtschaticum; L-C1qDC-1 protein; immune response
45
1. Introduction C1q, the initiating subcomponent of the classical pathway of the complement
47
system, is a versatile immune molecule. This molecule participates in an array of
48
immune responses that are dependent on its globular C1q (gC1q) domain, which can
49
bind a variety of self and non-self ligands (Färber et al., 2009; Kishore et al., 2004).
50
As the key link connecting innate and adaptive immunity, C1q has the ability to bind
51
immune complexes. This binding triggers activation of the classical complement
52
pathway and induces a wide variety of immune responses, such as pathogen
53
recognition (Matsushita et al., 2004), activation of the complement system (Kishore
54
and Reid, 2000), phagocytosis of bacteria (Tahtouh et al., 2009), and mediation of cell
55
migration (Bohlson et al., 2007). In addition, the broad-spectrum ligand-binding
56
potential of C1q fuels its functional flexibility. C1q also engages in an array of
57
processes that are completely independent of complement activation (Nayak et al.,
58
2010), as is evident in the case of microglial activation in the central nervous system
59
and maintenance of immune tolerance via clearance of apoptotic cells.
SC
M AN U
TE D
EP
AC C
60
RI PT
46
In recent years, C1q domain-containing (C1qDC) proteins have been defined as a
61
family that consists of all proteins containing a gC1q domain at their C-terminus
62
(Carland and Gerwick, 2010; Ghai et al., 2007). More than 30 proteins have been
63
identified as members of this family. The domain organization of these proteins
64
primarily includes a leading signal peptide, a collagen-like region, and a gC1q domain.
3
ACCEPTED MANUSCRIPT Based on their structural characteristics, C1qDC proteins are classified as
66
C1q/C1q-like proteins containing a collagen region at the N-terminus or globular head
67
C1q (ghC1q) proteins without a collagen region (Wang et al., 2012). These C1q
68
proteins are common among nearly all vertebrates. Interestingly, agnathan lampreys,
69
whose innate immune system is dissimilar to that of mammals, possess orthologs of
70
C1q.
RI PT
65
Lampreys are the surviving representatives of jawless vertebrates, which are
72
believed to have appeared approximately 500 million years ago (Osório and Rétaux,
73
2008). Because of their unique position in the chordate phylogeny, lampreys are a key
74
species for studying the evolutionary origin of the immune system (Amemiya et al.,
75
2007; Han et al., 2008). In earlier studies, immunologists struggled to study the
76
molecular mechanisms of the lamprey adaptive immune system, which is based on
77
variable lymphocyte receptors (VLRs) (Han et al., 2008). Thus, lampreys may be the
78
best model organism for research on the only known adaptive immune system not
79
based on immunoglobulin (Ig) molecules. However, the innate immune system of
80
lampreys presents great complexity. Although certain key complement components
81
are present, such as the C1q-like proteins, mannose-binding lectin (MBL),
82
MBL-associated serine proteases (MASP), Bf and C3, it remains unclear whether
83
lampreys have a complement pathway.
AC C
EP
TE D
M AN U
SC
71
84
In this study, we identified a novel C1q family member (designated L-C1qDC-1) in
85
Lethenteron camtschaticum, which differs from the C1q protein previously identified
86
in lampreys that acts as a lectin (Matsushita et al., 2004). Additionally, we revealed 4
ACCEPTED MANUSCRIPT that an interaction between L-C1qDC-1 and VLRB in L.camtschaticum plays a
88
prevalent role in L.camtschaticum immune responses.
89
2. Materials and Methods
90
2.1. Animals
RI PT
87
In December 2014, twenty adult L.camtschaticum specimens (length: 48-60 cm,
92
weight: 112-274 g) were collected from the Songhua River in Heilongjiang Province,
93
China, and were kept in fiber-reinforced plastic (FRP) tanks with running freshwater
94
at Liaoning Normal University. Additionally, two New Zealand rabbits were obtained
95
from Dalian Medical University, and six BALB/c mice were obtained from Beijing
96
Kwinbon Biotechnology Co.LTD.
97
2.2. Cloning of the full-length cDNA of the L-C1qDC-1 gene
TE D
M AN U
SC
91
A C1qDC homolog from L.camtschaticum was obtained through analysis of a liver
99
EST library using the Basic Local Alignment Search Tool X (BLASTx) of the
100
National Center for Biotechnology Information (NCBI). Total RNA was extracted
101
from L.camtschaticum livers using the Catrimox-14™ RNA Isolation Kit (TaKaRa,
102
Japan) and then converted to cDNA with reverse transcriptase (Promega, USA). The
103
full-length cDNA was amplified using a 3’-RACE (rapid amplification of cDNA ends)
104
or 5’-RACE Core Set Kit with the 3’- and 5’-RACE primers shown in Table 1. The
105
PCR product was purified and cloned into the pMD19-T vector using a DNA ligation
106
kit (TaKaRa, Japan) prior to DNA sequencing.
107
2.3. Amino acid sequence and phylogenetic analyses
AC C
EP
98
5
ACCEPTED MANUSCRIPT The amino acid sequence deduced from the L.camtschaticum L-C1qDC-1 gene was
109
analyzed using online tools available at http://www.expasy.org/tools/scanprosite. Total
110
amino acid sequence alignments of C1qDC family members, including L-C1qDC-1,
111
were performed using ClustalX 1.81 with the default settings. The obtained results
112
were converted into MEGA format and imported into MEGA 3.1 to construct a
113
phylogenetic tree using the neighbor-joining (NJ) method and 1,000 bootstrapped
114
replicates. Homology analysis of L-C1qDC-1 and C1q-like sequences was performed
115
using BLASTx from NCBI. Glycosylation site and functional domain analyses of
116
L-C1qDC-1
117
http://www.cbs.dtu.dk/sevices/NetOGlyc/ and http://smart.embl-heidelberg.de/.
118
2.4. Expression and purification of the rL-C1qDC-1 protein
were
also
M AN U
SC
RI PT
108
conducted
using
online
tools
at
The open reading frame (ORF) of L-C1qDC-1, flanked by EcoRI and HindIII
120
restriction sites, was amplified and subcloned into the pCold I vector with a histidine
121
(His) tag. Escherichia coli (E. coli) RosettaBlue (DE3) containing the pCold I
122
-rL-C1qDC-1 plasmid was then cultured in 0.5 L of LB broth containing 30
123
µg/mL kanamycin (Sangon Biotech, China) at 37°C for 3 h. When the OD600 reached
124
0.7, isopropyl-β-D-thiogalactopyranoside (IPTG) (Sangon Biotech, China) was added
125
to a final concentration of 1 mmol/L to induce protein expression. After 24 h of
126
culture with shaking, cells were harvested via centrifugation at 6,000 rpm for 10 min
127
at 4°C. The cell pellets were then resuspended, and the supernatants were purified to
128
obtain the rL-C1qDC-1 protein under previously described conditions (Pang et al.,
129
2015). Protein concentrations were estimated via the Bradford method using a
AC C
EP
TE D
119
6
ACCEPTED MANUSCRIPT Bicinchoninic Acid (BCA) Protein Assay Kit (Beyotime, China). The purified
131
rL-C1qDC protein was then analyzed by 12% SDS-PAGE and stained with
132
Coomassie Brilliant Blue (Sangon Biotech, China).
133
2.5. Production, purification and specificity of anti-rL-C1qDC-1 antibodies (Abs)
134
and western blotting
RI PT
130
Two New Zealand white rabbits were subcutaneously injected with purified
136
rL-C1qDC-1 protein (400 µg/rabbit) mixed with complete Freund’s adjuvant (CFA)
137
(Sigma, USA) at a 1:1 ratio, as described (Pang et al., 2012). For determination of the
138
antiserum titers via enzyme-linked immunosorbent assay (ELISA), 380 ng of the
139
rL-C1qDC-1 protein was diluted in 100 µL of polyclonal anti-rL-C1qDC-1 Ab at
140
different dilutions (1,000-fold to 512,000-fold) in each well of a 96-well ELISA plate.
141
For western blotting, total serum proteins were extracted from L.camtschaticum
142
(Beyotime, China), and protein concentrations were determined using a BCA Protein
143
Assay Kit (Beyotime, China). A total of 10 µg of purified rL-C1qDC-1 and 100 µg of
144
native L-C1qDC-1 protein from different L.camtschaticum tissues were then
145
subjected to 12% SDS-PAGE and transferred to nitrocellulose (NC) membranes.
146
These membranes were blocked with 5% skim milk and incubated with rabbit
147
anti-rL-C1qDC-1 Ab (1,000-fold dilution) overnight at 4°C, followed by incubation
148
with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (5,000-fold
149
dilution). The membranes were developed using an enhanced chemiluminescence
150
(ECL) substrate (Beyotime, China). Of the two batches of polyclonal Abs from the
151
two rabbits, we chose the batch from the rabbit with the higher titer for the subsequent
AC C
EP
TE D
M AN U
SC
135
7
ACCEPTED MANUSCRIPT experiments. To generate mouse anti-rL-C1qDC-1 monoclonal Abs (mAbs), BALB/c
153
mice were immunized with the recombinant L-C1qDC-1. After four immunizations,
154
the spleen cells of an immunized mouse were fused with SP2/0 myeloma cells.
155
Culture medium containing hypoxanthine, aminopterin, and thymidine was used for
156
screening of the fused hybridoma cells. Fourteen days after the cellfusion, the parent
157
cells were diluted to 100 cells in 10 mL of mediumand cultured in a 96-well cell
158
culture microplate (0.1 mL per well). The Abs secreted by the different clones were
159
then assayed for their ability tobind to the antigen (Ag) using ELISA and an
160
immunodot blot. The most productive and stable clone was selected for future use. To
161
obtain a large number of Abs, hybridoma cells were injected into the peritoneal cavity
162
of mice. Ab-richascites fluid was then collected, and the Abs were purified using
163
proteinG-Sepharose (GE Healthcare) chromatography.
164
2.6. Quantitative real-time PCR (Q-PCR)
TE D
M AN U
SC
RI PT
152
To obtain high-quality RNA, we prepared samples of fresh liver, intestine,
166
supraneural body, and blood from each of three L.camtschaticum specimens. The
167
extraction of leukocytes from the blood was performed as described previously (Pang
168
et al., 2015). Total RNA was extracted from each L.camtschaticum tissue sample
169
using TRIzol (Invitrogen, USA), and the RNA was treated with DNase I (TaKaRa,
170
China). Reverse transcription was then performed as previously described (Pang et al.,
171
2015). Q-PCR was conducted with the TaKaRa SYBR® PrimeScriptTM RT-PCR Kit
172
according to the manufacturer’s protocol. Each reaction contained 1×SYBR Premix
173
Ex Taq, 10 µM each primer, and 2 µL of cDNA (50 ng/µL) in a final volume of 25 µL.
AC C
EP
165
8
ACCEPTED MANUSCRIPT 174
Amplification was performed in a TaKaRa PCR Thermal Cycler Dice Real Time
175
System with the following parameters: initial denaturation at 95°C for 30 s to activate
176
the DNA polymerase, followed by 40 cycles of 5 s at 95°C, 30 s at 55°C, and 30 s at
177
72°C.
178
5’-GCTGAAGGAGGGAGATGAGG-3’
179
5’-AGTCGGGAAACAAGAGAAAACC-3’ (reverse). The GAPDH-specific primers
180
were
181
5’-GTCTTCTGCGTTGCCGTGT-3’
182
dehydrogenase (GAPDH) was amplified as an internal control. Each sample was
183
analyzed in triplicate using the Thermal Cycler Dice Real Time System analysis
184
software (TaKaRa, China).
185
2.7. Immunohistochemical staining
primers (forward)
5’-AACCAACTGCCTGGCTCCT-3’
and
(forward)
and
Glyceraldehyde3-phosphate
TE D
M AN U
(reverse).
were
RI PT
L-C1qDC-1-specific
SC
The
Tissues were fixed overnight with 4% paraformaldehyde in PBS at 4°C and then
187
embedded in paraffin. These paraffin-embedded specimens were sectioned at a
188
thickness
189
3-aminopropyltriethoxy silane (APES). The tissue sections were then de-waxed with
190
xylene and dehydrated using a series of successively diluted alcohol. Endogenous
191
peroxidase was inactivated by treating the sections with 0.3% hydrogen peroxide.
192
Next, the sections were blocked with 10% normal donkey serum for 1 h at room
193
temperature and incubated with the anti-rL-C1qDC-1 polyclonal Ab (1 µg/mL) for 3 h
194
at room temperature, followed by the addition of HRP-conjugated goat anti-rabbit IgG
195
(100-fold dilution) and rinsing with PBS. Normal rabbit IgG was used as a negative
4
µm
and
collected
on
glass
slides
precoated
with
AC C
of
EP
186
9
ACCEPTED MANUSCRIPT control. Subsequently, the slides were stained with diaminobenzidine (DAB) and
197
counterstained with hematoxylin. Following dehydration, the sections were passed
198
through successively diluted concentrations of xylene for 15 min each and then
199
mounted in neutral resin.
200
2.8. Co-immunoprecipitation experiments and western blotting
RI PT
196
L.camtschaticum serum samples were incubated with 1 µg of an anti-VLRB mAb
202
(or anti-IgG mAb) and the anti-rL-C1qDC-1 polyclonal Ab for 2 h at 4°C. Protein
203
G-agarose was then added to each sample, followed by incubation at 4°C for 4 h and
204
then centrifugation to collect the precipitated proteins. The samples were
205
subsequently analyzed via 12% SDS-PAGE and transferred to NC membranes
206
(Millipore).
207
anti-rL-C1qDC-1 primary Abs, the proteins were detected with HRP-labeled goat
208
anti-mouse or goat anti-rabbit secondary Ab and were revealed via ECL (Pierce,
209
USA).
incubation
with
anti-VLRB
(or
anti-IgG)
and
EP
TE D
Following
M AN U
SC
201
To explore the relationship between IgG and the L-C1qDC-1 proteins, we also used
211
an NC membrane carrying IgG and L-C1qDC-1 proteins, which were previously
212
separated via 15% SDS-PAGE. The NC membrane was blocked with 5% skim milk
213
and then incubated with 40 µg/mL L-C1qDC-1 protein at 4°C overnight. Following
214
incubation with anti-L-C1qDC-1 Ab, the NC membrane was washed and subjected to
215
western blotting, as described above.
216
2.9. Intracellular immunofluorescence staining
AC C
210
10
ACCEPTED MANUSCRIPT HeLa and MCF-7 cells were treated with L.camtschaticum serum for 10 min at
218
16°C. The cells were then washed twice with PBS, fixed and permeabilized for 10
219
min using 0.1% Triton X-100, followed by blocking with normal 10% donkey serum
220
for 2 h and incubation with 1 µg of anti-VLRB and anti-rL-C1qDC-1 Abs (200-fold
221
dilution) at 4°C overnight. After overnight incubation, the cells were washed twice
222
with PBS and then incubated with Alexa Fluor 488-labeled donkey anti-mouse IgG
223
(400-fold) and Alexa 555-labeled donkey anti-mouse IgG (400-fold dilution).
224
Following
225
4’,6-diamidino-2-phenylindole (DAPI) (200-fold dilution). After two washes with
226
PBS, the coverslips were mounted on glass slides along with drops of antifade
227
solution. Immunofluorescence was then visualized and captured with a Zeiss LSM
228
780 inverted microscope (Carl Zeiss, Inc.) and analyzed using Zeiss ZEN software. At
229
the same time, we incubated MCF-7 cells with Alexa 488-conjugated VLRB and
230
Alexa 555-conjugated L-C1qDC-1 protein for 2 h at 37°C in the dark, followed by
231
three washes with PBS. Finally, 3D-SIM images of the cells were acquired on the
232
DeltaVision OMX V3 imaging system (Applied Precision) using a 100×1.4 oil
233
objective (Olympus UPlanSApo), solid-state multimode lasers (488 nm and 561 nm)
234
and electron-multiplying charge-coupled device (CCD) cameras (Evolve 512×512,
235
Photometrics).
236
3. Results
237
3.1. Cloning and amino acid sequence analysis of L.camtschaticum L-C1qDC-1
238
cDNA
more
washes
with
PBS,
the
cells
were
stained
with
AC C
EP
TE D
M AN U
two
SC
RI PT
217
11
ACCEPTED MANUSCRIPT We identified a fragment whose nucleotide sequence shared high homology with
240
C1qDC homologs from other vertebrate species. Subsequent 3’-and 5’-RACE using
241
primers designed based on this fragment resulted in the successful isolation of a
242
full-length L-C1qDC-1 cDNA of 1,662 bp. This cDNA has a 711-bp ORF that
243
encodes 236 amino acid residues, a 107-bp 5’-untranslated region (UTR) and an
244
844-bp 3’-UTR with a polyadenylation signal (AATAAA). The amino acid sequence
245
deduced from the L.camtschaticum L-C1qDC-1 cDNA demonstrated sequence
246
similarity 41.9%-62.1% and identity 21.0%-42.4% from other vertebrates by the
247
MatGAT software. Alignment revealed a strongly conserved C1q domain, which plays
248
a significant role in binding a variety of ligands, at the C-terminus of the protein.
249
L.camtschaticum L-C1qDC-1 contains a leading signal peptide whose splice site is
250
between the seventeenth and eighteenth amino acids in the sequence, in addition to a
251
collagen-like region and a globular C1q domain. In the L-C1qDC-1 protein, there is
252
also an N-glycosylation site (Asn172) that contains the important modification function.
253
BLASTx analysis showed that L-C1qDC-1 consistently shared 44% identity with the
254
L.camtschaticum C1q-like protein, which demonstrated that L-C1qDC-1 is quite
255
different from the C1q-like protein. Thus, L-C1qDC-1 is a novel C1q
256
L.camtschaticum family member (Fig. 1).
257
3.2. Phylogenetic analysis of L.camtschaticum L-C1qDC-1
AC C
EP
TE D
M AN U
SC
RI PT
239
258
To investigate the evolutionary relationships between L.camtschaticum L-C1qDC-1
259
and its counterparts, we constructed an NJ tree based on the amino acid sequences of
260
C1qDC members. The tree suggested that all members of the C1q family can be 12
ACCEPTED MANUSCRIPT classified into two clusters. The first cluster is divided into three branches (C1qA,
262
C1qB, C1qC), following lower to higher evolutionary relationships according to the
263
evolutionary history. In the second cluster, the L.camtschaticum L-C1qDC-1 and the
264
L.camtschaticum hagfish and sea urchin C1q-like sequences are clustered separately
265
at the bottom of the evolutionary tree, indicating that they exhibit a unique position in
266
the evolutionary history (Fig. 2).
267
3.3. Expression and purification of the rL-C1qDC-1 protein
SC
RI PT
261
To express recombinant L-C1qDC-1 in E. coli RosettaBlue (DE3), the mature
269
protein-coding region, which encodes 236 amino acids of L-C1qDC-1, was generated
270
via PCR and cloned between the EcoRI and HindIII sites of the pCold I vector.
271
Amplification of the L-C1qDC-1 gene by PCR produced a single amplified 660-bp
272
DNA fragment encoding a mature L-C1qDC-1 protein with a length of 236 amino
273
acids. DNA sequencing confirmed that the cDNA sequence was identical to the
274
reported sequence. Following induction with 0.1 mM IPTG, rL-C1qDC-1 was
275
expressed as a His-tagged fusion protein in E. coli RosettaBlue (DE3). The purified
276
rL-C1qDC-1 migrated as a single band in a 12% SDS-PAGE gel, with a molecular
277
mass of approximately 26 kDa, consistent with the molecular mass predicted from the
278
DNA sequence (Fig. 3).
279
3.4. Titer and specificity analysis of Abs against the rL-C1qDC-1 protein
AC C
EP
TE D
M AN U
268
280
Polyclonal Abs against the full ORF of the recombinant L-C1qDC-1 protein were
281
generated through subcutaneous injection of male New Zealand white rabbits with the
13
ACCEPTED MANUSCRIPT purified rL-C1qDC-1 protein. The titer of the obtained anti-L-C1qDC-1 serum was
283
determined via ELISA at different dilutions (1,000-fold to 512,000-fold). The valence
284
of the Abs secreted by the different clones was also assayed using ELISA. We chose
285
clone MC-7, which has the highest valence of the sixteen clones, for our experiments.
RI PT
282
The specificity of the Abs was confirmed through western blot assays using the
287
recombinant L-C1qDC-1 protein and serum from L.camtschaticum. In parallel, we
288
used the entire gel separation range of 12% SDS-PAGE to examine the rL-C1qDC-1
289
protein and total serum protein bands stained with Coomassie Brilliant Blue. The
290
slight discrepancy between the predicted size and the actual size of the full-length
291
L-C1qDC-1 protein, as determined by western blotting, may have been due to the fact
292
that the pCold I vector is no more than 2kDa in size (Fig. 4).
293
3.5.
294
L.camtschaticum tissues
M AN U
SC
286
expression
and
distribution
TE D
mRNA
of
L-C1qDC-1
in
different
The expression of L-C1qDC-1 mRNA was determined via real-time PCR using
296
L-C1qDC-1-specific primers, as previously described. L-C1qDC-1 mRNA was highly
297
expressed in the liver and intestine, whereas leukocytes and the supraneural body
298
exhibited lower expression levels (Fig. 5A). Additionally, immunohistochemistry was
299
performed with the anti-L-C1qDC-1 polyclonal Ab, and the results were identical to
300
the Q-PCR results. Additionally, light microscopy revealed high L-C1qDC-1 protein
301
expression in the liver and intestine of L.camtschaticum and lower expression in the
302
supraneural body (Fig. 5B).
AC C
EP
295
14
ACCEPTED MANUSCRIPT 303
3.6. Interaction of the VLRB and L-C1qDC-1 proteins The potential association between VLRB and L-C1qDC-1 was examined in
305
L.camtschaticum serum via co-immunoprecipitation. The results showed that the
306
anti-L-C1qDC-1 Ab could precipitate VLRB (a 35 kDa protein) from the serum,
307
similar to previously reported findings (Wu F, 2013). At the same time, the
308
anti-VLRB polyclonal Ab could precipitate L-C1qDC-1 (a 26 kDa protein) (Fig. 6A).
SC
RI PT
304
Furthermore, we found that L-C1qDC-1 and VLRB were partially associated,
310
forming a complex in L.camtschaticum serum. When MCF-7 and HeLa cells were
311
incubated with L.camtschaticum serum, the complex of L-C1qDC-1 and VLRB was
312
deposited on the surface of the cells. In addition, fluorescent confocal analysis further
313
confirmed the deposition and interaction of VLRB and L-C1qDC-1 on the surface and
314
in the cytoplasm of target HeLa cells and MCF-7 cells (Fig. 6B). 3D-SIM images of
315
the cells also showed that the VLRB and L-C1qDC-1 proteins exhibited the same
316
orientation along the Z axis of observation (Fig. 6C).
317
4. Discussion
TE D
EP
AC C
318
M AN U
309
All vertebrates, excluding agnathans, share a similar complement system. The
319
classical complement pathway has been suggested to have evolved from the lectin
320
pathway, although it adapted to become an Ig-recognizing system with the advent of
321
adaptive immunity during evolutionary history (Nayak et al., 2012). In
322
L.camtschaticum, an extant group of jawless vertebrates, the only component systems
323
appear to be the alternative and lectin pathways. Additionally, this group completely
15
ACCEPTED MANUSCRIPT 324
lacks the known major components of adaptive immunity. C1q is a target recognition protein of the classical complement pathway that serves
326
as a major link between innate and adaptive immunity. Recent findings have raised
327
the possibility that certain C1q-related proteins possess lectin activity and that
328
C1q-mediated complement activation occurs in even more primitive species (Yu et al.,
329
2008).
SC
RI PT
325
In this study, we identified a novel L-C1qDC-1 gene in L.camtschaticum. Sequence
331
analysis illustrated that L-C1qDC-1 shared high homology with sequences from other
332
advanced vertebrates, whereas it only consistently shared 44% identity with the
333
L.camtschaticum C1q-like protein. Nevertheless, there are clear differences between
334
these sequences in terms of the structure of the tumor necrosis factor (TNF)
335
superfamily. However, these sequences all exhibit eight conserved domains that
336
constitute the hydrophobic core of C1q, which explains how C1q can bind to many
337
ligands. Further results of this study showed that the L-C1qDC-1 gene encodes 236
338
amino acid residues and contains a leading signal peptide, a collagen-like region, and
339
a gC1q domain that are extremely conserved. The L-C1qDC-1 protein also contains a
340
signal peptide with asplice site located at amino acids 17-18 and does not exhibit any
341
transmembrane structure; thus, it is likely a secretory protein. Additionally, there is an
342
N-glycosylation site in L-C1qDC-1. Due to the special status of L.camtschaticum,
343
further evaluation of the L-C1qDC-1 molecule will provide important information
344
regarding the function and evolution of the C1q family. To characterize this novel
345
molecule, we used real-time PCR to analyze its expression pattern. The mRNA
AC C
EP
TE D
M AN U
330
16
ACCEPTED MANUSCRIPT expression of L-C1qDC-1 was highest in the liver and intestine and lower in the
347
supraneural body and leukocytes. Because the relative expression was very low in
348
other tissues of L.camtschaticum, we did not show this expression in detail.
349
Immunohistochemical staining assays more clearly demonstrated L-C1qDC-1
350
expression in the tissues, as mentioned above.
351
Jawless
fish,
and
especially
L.camtschaticum,
RI PT
346
exhibit
an
alternative
lymphocyte-based adaptive immune system based on somatically diversified
353
leucine-rich repeat (LRR)-based Ag receptors, referred to as VLRs. The
354
L.camtschaticum B-like lymphocyte lineage has been shown to express the
355
anticipatory receptor VLRB (Das et al., 2013). VLRBs are the counterparts of the Ig
356
that jawed vertebrates use for Ag recognition and complement activation.
357
L.camtschaticum lacks lymphatic organs, a spleen, and a thymus, and L-C1qDC-1
358
mRNA is distributed in the intestine, liver, leukocytes and supraneural body.
359
Interestingly, Cooper (Alder et al., 2008) reported VLRB expression in lymphocytes
360
from the blood, kidneys and typhlosoles. The somewhat similar distribution of the
361
L-C1qDC-1 protein and VLRB suggested that L-C1qDC-1 might also be involved in
362
the innate immune system, though whether it mediates complement activity is still
363
unknown. The blood circulation system is an important immune system for
364
transporting immune molecules and immune cells, and our results revealed interaction
365
of the L-C1qDC-1 protein with VLRB in L.camtschaticum serum. Moreover, analyses
366
using confocal microscopy and the DeltaVision OMX V3 imaging system revealed
367
the formation of complexes on the surface of target cells that might lead to
AC C
EP
TE D
M AN U
SC
352
17
ACCEPTED MANUSCRIPT 368
complement activation. Furthermore, we found that L-C1qDC-1 was primarily
369
located in the cytoplasm, and not in the nucleus. The complement system is a key component of the innate immune system and
371
plays an important role in the clearance of pathogens and apoptotic cells upon
372
its activation. It is well known that both IgG and IgM can activate the complement
373
system via the classical pathway through the binding of C1q to the Fc regions of these
374
Igs (Daha et al., 2011;Gadjeva et al., 2008). As previously stated, in humans and
375
mammals, C1q is the first subcomponent of the classical pathway of complement
376
activation and serves as a major link between classical pathway-driven innate
377
immunity and IgG-or IgM-mediated acquired immunity. Furthermore, in zebrafish,
378
C1qs can bind to heat-aggregated human IgG (Hu et al., 2010). Through
379
co-immunoprecipitation and western blotting experiments, we also found that there is
380
an interaction between the L-C1qDC-1 protein and IgG. It seems that L-C1qDC-1
381
exhibits a similar function to C1q in humans, playing an important role in immune
382
responses in L.camtschaticum (Supplementary Fig.1). We will further explore this
383
aspect in future research. Above all, these results indicated that L-C1qDC-1 might
384
primarily participate in VLRB-mediated and innate immune responses, which is key
385
to obtaining a detailed understanding of the origin and evolution of the complement
386
and immune systems.
387
5. Conclusions
388
AC C
EP
TE D
M AN U
SC
RI PT
370
This report presents the characterization of a novel C1qDC protein (designated as
18
ACCEPTED MANUSCRIPT L-C1qDC-1) from L.camtschaticum. Expression pattern analysis showed that
390
L-C1qDC-1 participates in theimmune responses of L.camtschaticum. This work may
391
play an important role in achieving understanding of the universal functions of
392
C1qDC proteins in other species and suggests that these proteins could serve as
393
pattern recognition molecules in immunotherapy.
394
Acknowledgments
SC
RI PT
389
This work was supported by the Chinese Major State Basic Research Development
395
Program (973 Program; Grant2013CB835304),
397
the Marine Public Welfare Project of State Oceanic Administration (No.201305016),
398
the Chinese National Natural Science Foundation (Grants 31170353 and 31202020), t
399
he Research Project of Liaoning Provincial Department of Education (No.
400
LJQ2014117) and the Science and Technology Project of Dalian (No. 2013E11SF056)
401
.
402
References
403 404 405 406 407 408 409 410 411 412 413 414 415 416
Alder, M.N., Herrin,B.R., Sadlonova, A., Stockard, C.R., Grizzle, W.E., Gartland, L.A., Gartland, G.L.,
EP
TE D
M AN U
396
AC C
Boydston, J.A., Turnbough, C.L., Cooper, M.D., 2008. Antibody responses of variable lymphocyte receptors in the lamprey. Nat Immunol. 9, 319-327. Amemiya CT, Saha N.R., Zapata A., 2007. Evolution and development of immunological structures in the lamprey. Curr Opin Immunol. 19, 535-541. Bohlson, S.S., Fraser, D.A., Tenner, A.J., 2007. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-termprotective immune functions. Mol Immunol. 44, 33-43. Carland, T.M., Gerwick, L., 2010. The C1q domain containing proteins: Where do they come from and what do they do? Dev Comp Immunol. 34, 785-790. Daha, N.A., Banda, N.K., Roos, A., Beurskens, F.J., Bakker, J.M., Daha, M.R., Trouw, L.A., 2011. Complement activation by (auto-) antibodies. Mol Immunol. 48, 1656-1665. Das, S., Hirano, M., Aghaallaei, N., Bajoghli, B., Boehm, T., Cooper, M.D., 2013. Organization of lamprey variable lymphocyte receptor C locus repertoire development. Proc Natl Acad Sci USA. 110,
19
ACCEPTED MANUSCRIPT 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458
6043-6048.
459
Figure Legends
Färber, K., Cheung, G., Mitchell, D., Wallis, R., Weihe, E., Schwaeble, W., Kettenmann, H., 2009. C1q, the recognition subcomponent ofthe classical pathway of complement, drives microglial activation. J Neurosci Res. 87, 644e652. Gadjeva, M.G., Rouseva, M.M., Zlatarova, A.S., Reid, K.B., Kishore, U., Kojouharova, M.S., 2008. Interaction of human C1q with IgG and IgM:revisited. Biochemistry. 47, 13093-13102. Ghai, R., Waters, P., Roumenina, L.T., Gadjeva, M., Kojouharova, M.S., Reid, K.B., Sim, R.B.,
RI PT
Kishore, U., 2007.C1q and its growing family. Immunobiology. 212, 253-266.
Han, B.W., Herrin, B.R., Cooper M.D., Wilson I.A., 2008. Antigen recognition by variable lymphocyte receptors. Science. 321, 1834-1837.
Hu, Y.L., Pan, X.M., Xiang, L.X., Shao, J.Z., 2010. Characterization of C1q in teleosts: insight into the molecular and functional evolution of C1q family and classical pathway. J Biol Chem. 5, 28777-28786.
SC
Kishore, U., Ghai, R., Greenhough, T.J., Shrive, A.K., Bonifati, D.M., Gadjeva, M.G., Waters, P., Kojouharova, M.S., Chakraborty, T., Agrawal, A., 2004. Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett. 95, 113-128.
Kishore, U., Reid, K.B., 2000. C1q: structure, function, and receptors. Immunopharmacology. 49,
M AN U
159-170.
Matsushita, M., Matsushita, A., Endo, Y., Nakata, M., Kojima, N., Mizuochi, T., Fujita, T., 2004. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin. Proc Natl Acad Sci U S A. 101, 10127-10131.
Nayak, A., Ferluga, J., Tsolaki, A.G., Kishore, U., 2010. The non-classical functions of the classical complemet pathway recognition subcomponent C1q. Immunol Lett. 131, 139-150. Nayak, A., Pednekar, L., Reid K.B., Kishore, U., 2012. Complement and non-complement activating
TE D
functions of C1q: a prototypical innate immune molecule. Innate Immun. 18, 350-363. Osório, J., Rétaux, S., 2008. The lamprey in evolutionary studies. Dev Genes Evol. 218, 221-235. Pang, Y., Liu, S., Zheng, Z., Liu, X., Li, Q., 2015. Identification and characterization of the lamprey IRF gene. Immnol Lett. 164, 55-64.
Pang, Y., Xiao, R., Liu, X., Li, Q., 2012. Identification and characterization of the lamprey
EP
high-mobility group box 1 gene. PloS One. 7, e35755. Tahtouh, M., Crog, F., Vizioli, J., Sautiere, P.E., Van, C.C., Salzet, M., Daha, M.R., Pestel, J., Lefebvre, C., 2009. Evidence for a novel chemotatic C1q domain-containing factor in the leech nerve cord. Mol
AC C
Immunol. 46, 523-531.
Wang, L., Wang, L., Zhang, H., Zhou, L., Siva, V.S., Song, L., 2012. A C1q domain conataining protein from scallop Chlamys farreri serving as pattern recognition receptor with heat-aggregated IgG binding activity. PloS One. 7, e43289. Wu, F., C, L., Liu, X., Wang, H., Su, P., Han, Y., Feng, B., Qiao, X., Zhao, J., Ma, N., Liu, H., Zheng, Z., Li, Q., 2013. Lamprey variable lymphocyte receptors mediate complement-dependent cytotoxicity. J Immunol. 190, 922-930. Yu, Y., Huang, H., Wang, Y., Yu, Y., Yuan, S., Huang, S., Pan, M., Feng, K., Xu, A., 2008. A novel C1q family member of amphioxus was revealed to have a partial function of vertebrate C1q molecule. J Immunol. 181, 7024-7032.
20
ACCEPTED MANUSCRIPT Fig. 1 Sequence alignment of L.camtschaticum L-C1qDC-1 and C1q-like
461
proteins.
462
A. L.camtschaticum L-C1qDC-1 and C1q-like molecules. BLASTx analysis of the
463
L-C1qDC-1 and C1q-like sequences showed that they consistently shared only 44%
464
identity.
465
http://smart.embl-heidelberg.de/. Signal peptides are highlighted in red; the
466
collagen-like region, in yellow; and the C1q domain, in green. The blue boxes mark
467
the eight conserved amino acid residues, and the red box represents the
468
N-glycosylation site.
469
B. Stick models of the functional domains in the L-C1qDC-1 gene. The three
470
loop-like regions indicate the omitted amino acids.
471
Fig. 2 Phylogenetic tree for L-C1qDC-1 based on the NJ method.
472
An NJ tree was constructed using the amino acid sequences of C1qDC proteins. The
473
numbers at the nodes indicate the bootstrap confidence values derived from 1,000
474
replications. The bar (0.1) indicates genetic distance. The accession numbers of the
475
amino acid sequences extracted from the NCBI protein database are as follows:
476
Human C1qA (P02745.2); Mouse C1qA (P98086.2); Rat C1qA (P31720.2); Bovine
477
C1qA (Q5E9E3.1); Dog C1qA (XP535367.1); Horse C1qA (XP001504311.1);
478
Opossum C1qA (XP001376435.1); Pig C1qA (Q69DL0.1); Rhesus C1qA
479
(XP001101837.1); Chicken C1qA (XP417654.2); Zebrafish C1qA (ACN62221.1);
480
Human C1qB (P02746.3); Mouse C1qB (P14106.2); Rat C1qB (P31721.2); Bovine
functional
domains
of
L-C1qDC-1
are
according
to
AC C
EP
TE D
M AN U
SC
The
RI PT
460
21
ACCEPTED MANUSCRIPT C1qB (Q2KIV9.1); Dog C1qB (XP544507.2); Horse C1qB (XP001501545.1);
482
Rhesus C1qB (XP001110783.1); Chicken C1qB (XP425756.2); Human C1qC
483
(P02747.3); Mouse C1qC (Q02105.2); Rat C1qC (P31722.2); Dog C1qC
484
(XP544508.2); Horse C1qC (XP001504308.1); Rhesus C1qC (XP001102196.1);
485
Chicken C1qC (XP417653.1); Zebrafish C1qC (ACN62223.1); Shark C1q-like
486
(AFK11213.1); Lamprey C1q-like (BAD22833.1); Hagfish C1q (BAM76761.1);
487
Urchin C1q-like (XP782700.1).
488
Fig. 3 SDS-PAGE analysis of the rL-C1qDC-1 protein expressed in E. coli
489
RosettaBlue.
490
A. SDS-PAGE analysis of the rL-C1qDC-1 protein expressed in E. coli RosettaBlue.
491
M, low-molecular-weight protein marker; Lane 1, induced expression of
492
RosettaBlue/pCold I; Lane 2, non-induced expression of RosettaBlue/pCold
493
I-L-C1qDC-1; Lane 3, induced expression of RosettaBlue/pCold I-L-C1qDC-1; Lane
494
4, supernatant; Lane 5, inclusion body.
495
B. Purified rL-C1qDC-1 protein. M, low-molecular-weight protein marker; Lane 1,
496
supernatant fluid from the sonicated bacterial cells; Lane 2, flow-through sample;
497
Lane 3, washing sample; Lane 4, the purified recombinant protein.
498
Fig. 4 Specificity analysis of Abs against the rL-C1qDC-1 protein.
499
Western blot analysis of the specificity of rabbit anti-L-C1qDC-1 polyclonal Abs and
500
mouse anti-L-C1qDC-1 mAbs. A. SDS-PAGE analysis of rL-C1q-DC-1 protein and
501
serum from L.camtschaticum. B. Western blotting showing the specificity of the
AC C
EP
TE D
M AN U
SC
RI PT
481
22
ACCEPTED MANUSCRIPT anti-rL-C1qDC-1polyclonal Abs. C. Western blotting showing the specificity of the
503
anti-rL-C1qDC-1mAb. M, pre-stained protein ladder; L-C1qDC-1, the purified
504
rL-C1qDC-1 protein; Serum, serum from L.camtschaticum.
505
Fig. 5 Q-PCR analysis and immunohistochemical staining of the L-C1qDC-1
506
protein in L.camtschaticum tissues.
507
A. Q-PCR analysis of the L-C1qDC-1 gene in L.camtschaticum, characterizing
508
L-C1qDC-1 mRNA expression in adult tissues. The mRNA levels of L-C1qDC-1 are
509
expressed as a ratio in relation to GAPDH mRNA levels, n=3.
510
B. a. Localization and distribution of the L-C1qDC-1 protein in L.camtschaticum
511
tissues, as observed via immunohistochemical staining. The tissue sections were
512
incubated with the anti-L-C1qDC-1 polyclonal Ab at 8 µg/mL. Normal rabbit IgG
513
served as a control. The tissues included the supraneural body, liver, and intestine.
514
Positive cells are indicated by red arrows. Scale bars: 50 µm, magnification: 40×, n=3.
515
b. Histogram showing statistics of the above results.
516
Fig.6
517
co-immunoprecipitation and laser scanning confocal microscopy analysis.
518
A. Co-immunoprecipitation of L-C1qDC-1 and VLRB from L.camtschaticum
519
serum.The anti-L-C1qDC-1 Ab precipitated the VLRB protein (35 kDa, Fig. a), and
520
the anti-VLRB mAb precipitated the L-C1qDC-1 protein (25 kDa, Fig. b).
521
S:supernatant; P:precipitation.
522
B. Colocalization of L-C1qDC-1 and VLRB, asdetermined via laser scanning
EP
TE D
M AN U
SC
RI PT
502
of
L-C1qDC-1
and
VLRB,
as
determined
via
AC C
Interaction
23
ACCEPTED MANUSCRIPT confocal microscopy analysis. MCF-7 and HeLa cells incubated with Abs. The
524
primary Abs consisted of mouse anti-VLRB mAbs and mouse anti-L-C1qDC-1 mAbs,
525
and the secondary Abs consisted of Alexa 488-labeled donkey anti-mouse IgG and
526
Alexa 555-labeled donkey anti-mouse IgG. The nuclei were stained with DAPI. Scale
527
bar, 5 µm.
528
C. Colocalization of L-C1qDC-1 and VLRB, as determined using the DeltaVision
529
OMX V3 imaging system. MCF-7 cells incubated with Alexa 488-conjugated VLRB
530
protein and Alexa 555-conjugated L-C1qDC protein. Scale bar, 5 µm.
531
Supplementary Fig. 1. Interaction of L-C1qDC-1 and IgG, as determined via
532
western blotting and co-immunoprecipitation.
533
A. Co-immunoprecipitation of L-C1qDC-1 and IgG. The anti-IgG mAbs precipitated
534
the L-C1qDC-1 protein (25 kDa) of L.camtschaticum serum, and anti-L-C1qDC-1 Ab
535
precipitated the L-C1qDC-1 protein as a negative control.
536
B. Interaction of L-C1qDC-1 and IgG, as determined via western blotting. The
537
L-C1qDC-1 and IgG proteins were separated by SDS-PAGE and then transferred to
538
an NC membrane and incubated with L-C1q-DC-1 (40 µg/mL). Bound L-C1qDC-1
539
was detected with an HRP-conjugated anti-L-C1qDC-1 Ab.
AC C
EP
TE D
M AN U
SC
RI PT
523
24
ACCEPTED MANUSCRIPT
M AN U
SC
Sequences 5'-GAGCCGCAGTACAACACAGTTCAAG-3' 5'-CAGGAAGCCGAGGTGAACCAGGATT-3' 5'-GATCTTGGCAGTGAAGGCTGACTTTGGC-3'
EP
TE D
5'-AAGTCTATTTTGTCTGCTTTCGGGCCGG-3' 5'-TTCAGCGGAAAGCCACGAGGAC-3' 5'-TCTATTTTGTCTGCTTTCGGGC-3‘
AC C
Primers. Name 3'RACE-F1 3'RACE-F2 5'RACE-R1 5'RACE-R2 L-C1qDC-1 F L-C1qDC-1 R
RI PT
Tab1. Specific primer sequences
ACCEPTED MANUSCRIPT
Fig. 1
B
AC C
EP
TE D
M AN U
SC
RI PT
A
5’UTR
SP
Collagen
C1q
3’UTR
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
Fig. 2
ACCEPTED MANUSCRIPT
A. M
1
2
3
4
5
KDa 97.2
97.2
66.4
M AN U
66.4
44.3
20.1
14.4
AC C
EP
TE D
44.3
29.0
M
SC
KDa
B.
RI PT
Fig. 3
29.0
20.1
14.4
1
2
3
4
ACCEPTED MANUSCRIPT
Fig.4
M L-C1q-DC-1
Anti-rL-C1q-DC-pAb Serum
L-C1q-DC-1 Serum A
SC M AN U EP AC C
L-C1q-DC-1
B
TE D
35KDa 25KDa
Anti-rL-C1q-DC-mAb
RI PT
SDS-PAGE
Serum C
ACCEPTED MANUSCRIPT
1.8 1.6
SC
Relative expressior level of L-C1q-DC-1
2
RI PT
Fig.5A
M AN U AC C
EP
TE D
L-C1qDC-1
GAPDH
1.4 1.2 1
0.8 0.6 0.4 0.2 0
Intestine
Leukocyte Supraneural body
Liver
ACCEPTED MANUSCRIPT
Liver
Supraneural body
SC M AN U TE D EP AC C
Anti-L-C1qDC-1-antibody
b. Relative expression of L-C1qDC-1 protein
Intestine
Normal-rabbit-IgG
a.
RI PT
Fig. 5B.
450 400 350 300 250 200 150 100 50 0
Intestine
Liver
Supraneural body
ACCEPTED MANUSCRIPT
RI PT
Fig. 6A a.
Anti-L-C1qDC-1 S P
SC
Sera
M AN U
VLRB
AC C
L-C1qDC-1
EP
Sera
TE D
b.
S
40KDa 35KDa
Anti-VLRB P 35KDa 25KDa
ACCEPTED MANUSCRIPT
VLRB
L-C1qDC-1
EP AC C
MCF-7
TE D
M AN U
Hela
SC
Nuclear
RI PT
Fig.6B Merge
ACCEPTED MANUSCRIPT
L-C1qDC-1 VLRB
L-C1qDC-1 VLRB
L-C1qDC-1 VLRB
AC C
EP
TE D
M AN U
L-C1qDC-1 VLRB
SC
RI PT
Fig. 6C
Z-axis
ACCEPTED MANUSCRIPT
Anti-IgG P
Anti-L-C1qDC-1 P
SC
A.
RI PT
Supplymentary Fig.1
M AN U
L-C1qDC-1
EP
AC C
25KDa
TE D
L-C1qDC-1 IgG L-C1qDC-1
B.
ACCEPTED MANUSCRIPT
Highlights 1. This report describes the identification and characterization of a novel C1qDC protein (designated as L-C1qDC-1) from Lethenteron camtschaticum. 2. This report represents that L-C1qDC-1 participated in VLRB-mediated and innate
RI PT
immune responses, and it is important to understand the origin and evolution of the complement and immune systems. It may play an important role of
AC C
EP
TE D
M AN U
SC
understanding the universal functions of C1qDC proteins in other species.